In the southern portion of India, Amrutanjan Healthcare is one company that is doing extremely in the present and has been doing so since 1893 actually. Even they are in India at the moment it is not that many people are aware of their amazing work, which is why we’re here to provide a brief article regarding Amrutanjan Healthcare’s networth, ownership, the position of CEO and their headquarters.
| Brand name/Company name | Amrutanjan Health Care Limited |
| Year of establishment | 1893 |
| The country of the origin (headquarters) | India (Chennai, Tamil Nadu) |
| Owner/Founder | Public company founded by K. Nageswara Rao |
| CEO Name | S. Sambhu Prasad (Chairman & Managing Director) |
| Industry | Medical as well as OTC consumer products |
| Net worth | Rs288.49 crore (FY24 shareholders” equity) |
| Total revenue for 2024 | Rs421.23 crore (FY22 operating revenue) |
About the Company
Amrutanjan has been an alternative name for quick headache relief since it introduced its famous balm that relieves pain in 1893. Over the years the company has expanded and expanded its product line however, it has maintained its core goal that it would provide “fast alleviation.” Amrutanjan, apart from its traditional balm, is now offering more recent product lines such as Comfy (women’s sanitation) along with Electro+ (hydration drinks). Just to be clear the main head office is located at Mylapore, Chennai.
Current Status
Amrutanjan Healthcare is a publicly traded company that is headquartered within Chennai and has manufacturing facilities spread throughout Tamil Nadu and Telangana, too. The company has seen a lot of growth during FY24 and FY25, slowly expanding its scope of businesses in various categories, including women’s hygiene, pain relief and hydration drinks. In addition the fact that its products are available via online and quick-commerce websites, and that’s a important plus point.
Recent Updates and Future Outlook
Amrutanjan in the quarter that ended in the month of June (Q1 FY26) the net sales totalled approximately Rs94 crores. This is nearly 12% more over the previous year. The profit after tax stood around Rs8.31 crores. The company is able to reap the benefits of the upward trend that was established in FY25. It was driven by increase in sales of the hygiene and pain relief segments.